Best Practice For Long-Term Control of Atopic Dermatitis
By Dr Linda Vogelnest
What is best practice for long-term control of atopic dermatitis?
The safest treatment plan (often multimodal) effective for each patient & achievable for owners!
Safe options include: allergen-immunotherapy (based on intradermal and/or serum testing), potent topical steroids (twice weekly), cleansing/bathing (to help reduce infection risk), barrier repair (fatty acids, moisturizing after/between baths), antihistamines. Additional low-dose pred (≤0.5mg/kg 1-2 times weekly) can be safe with monitoring.
Higher risk options (known immunosuppressive risks) include: Apoquel, Cyclosporin, pred (>0.5mg/kg twice wkly): these are more reliably effective and easy options (if affordable), but not the safest options for our patients!
Recent Articles
Preclinical Evaluation Of The Novel, Orally Bioavailable Selective Inhibitor Of Nuclear Export (SINE) KPT-335 In Spontaneous Canine Cancer
By : Cheryl A. London, Luis Feo Bernabe, Sandra Barnard, William C. Kisseberth, Antonella Borgatti, Mike Henson, Heather Wilson, Kiersten Jensen, Daisuke Ito, Jaime F.
Chronic Urinary Bladder Torsion Causing Urinary Incontinence In A Cat
By : Daniel R James, David Collins, Philippa J Johnson and Andrew M Marchevsky Case Summary A 10-month-old female spayed domestic shorthair cat was presented
X Linked Myotubular Myopathy In Rottweiler Dogs
By : G Diane Shelton, Branden E Rider, Georgina Child, Sophia Tzannes, Ling T Guo, Behzad Moghadaszadeh, Emily C Troiano, Bianca Haase, Claire M Wade
Maintenance Therapy With Toceranib Following Doxorubicin Based Chemotherapy For Canine Splenic Hemangiosarcoma
By : Heather L. Gardner, Cheryl A. London, Roberta A. Portela, Sandra Nguyen, Mona P. Rosenberg, Mary K. Klein, Craig Clifford, Douglas H. Thamm, David
Psuedoangiomatous Squamous Cell Carcinoma In The Oral Cavity Of A Dog
By : Tim Cushing, Sandra Barnard, Rebekah Fleis, Rachel Peters Abstract An 8-year-old, spayed, female Labrador Retriever mixed-breed dog was presented to the Cornell University
Evaluation Of The Adverse Event Profile And Pharmacodynamics of Toceranib Phosphate Administered To Dogs
By : Luis Feo Bernabe, Roberta Portela, Sandra Nguyen, William C Kisseberth, Michael Pennell, Mark F Yancey and Cheryl A London Background The receptor kinase
